Effect of ex vivo culture conditions on immunosuppression by human mesenchymal stem cells

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Lee, Myoung Woo ^a   Kim, Dae Seong ^a   Ryu, Somi ^a   Jang, In Keun ^b   Kim, Hye Jin ^a   Yang, Jin Mo ^a   Lee, Doo Hoon ^b   Lee, Soo Hyun ^a   Son, Meong Hi ^a   Cheuh, Hee Won ^c   Jung, Hye Lim ^a   Yoo, Keon Hee ^a   Sung, Ki Woong ^a   Koo, Hong Hoe ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Biomedical Research Institute   (South Korea)

^c Dong A University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ENDOGLIN; SMALL INTERFERING RNA; THY 1 ANTIGEN; MITOGENIC AGENT;

ADULT; ARTICLE; CELL DENSITY; CELL STRUCTURE; DNA MICROARRAY; DOWN REGULATION; EX VIVO STUDY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNE DEFICIENCY; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MALE; MESENCHYMAL STEM CELL; NORMAL HUMAN; T LYMPHOCYTE; UPREGULATION; CELL COUNT; CELL CULTURE; CELL PROLIFERATION; CELL SEPARATION; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MESENCHYMAL STROMA CELL; METABOLISM; METHODOLOGY; MIDDLE AGED; DRUG EFFECTS; PROCEDURES;

ADULT; CELL COUNT; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELL SEPARATION; CELLS, CULTURED; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; IMMUNOSUPPRESSION; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; MITOGENS; T-LYMPHOCYTES;

EID: 84879334967     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/154919     Document Type: Article

References (37)

1. Dominici M., le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F. C., Krause D. S., Deans R. J., Keating A., Prockop D. J., Horwitz E. M., Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006 8 4 315 317 2-s2.0-33747713246 10.1080/14653240600855905 (Pubitemid 44269669)
2. Salem H. K., Thiemermann C., Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 2010 28 3 585 596 2-s2.0-77950551326 10.1002/stem.269
3. Polchert D., Sobinsky J., Douglas G. W., Kidd M., Moadsiri A., Reina E., Genrich K., Mehrotra S., Setty S., Smith B., Bartholomew A., IFN-γ activation of mesenchymal stem cells for treatment and prevention of graft versus host disease. European Journal of Immunology 2008 38 6 1745 1755 2-s2.0-49649106257 10.1002/eji.200738129
4. Pittenger M. F., Mackay A. M., Beck S. C., Jaiswal R. K., Douglas R., Mosca J. D., Moorman M. A., Simonetti D. W., Craig S., Marshak D. R., Multilineage potential of adult human mesenchymal stem cells. Science 1999 284 5411 143 147 2-s2.0-0033515827 10.1126/science.284.5411.143 (Pubitemid 29282067)
5. Russell K. C., Phinney D. G., Lacey M. R., Barrilleaux B. L., Meyertholen K. E., O'Connor K. C., In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells 2010 28 4 788 798 2-s2.0-77950991204 10.1002/stem.312
6. Silva W. A. Jr., Covas D. T., Panepucci R. A., Proto-Siqueira R., Siufi J. L. C., Zanette D. L., Santos A. R. D., Zago M. A., The profile of gene expression of human marrow mesenchymal stem cells. Stem Cells 2003 21 6 661 669 2-s2.0-0142165904 (Pubitemid 37329159)
7. Wagner W., Feldmann R. E. Jr., Seckinger A., Maurer M. H., Wein F., Blake J., Krause U., Kalenka A., Bürgers H. F., Saffrich R., Wuchter P., Kuschinsky W., Ho A. D., The heterogeneity of human mesenchymal stem cell preparations-evidence from simultaneous analysis of proteomes and transcriptomes. Experimental Hematology 2006 34 4 536 548 2-s2.0-33645322638 10.1016/j.exphem.2006.01.002
8. Wagner W., Senescence is heterogeneous in mesenchymal stromal cells: kaleidoscopes for cellular aging. Cell Cycle 2010 9 15 2923 2924 2-s2.0-77956837158 10.4161/cc.9.15.12741
9. Seghatoleslami M. R., Tuan R. S., Cell density dependent regulation of AP-1 activity is important for chondrogenic differentiation of C3H10T1/2 mesenchymal cells. Journal of Cellular Biochemistry 2002 84 2 237 248 2-s2.0-0035671706 10.1002/jcb.10019 (Pubitemid 34033282)
10. Ho A. D., Wagner W., Franke W., Heterogeneity of mesenchymal stromal cell preparations. Cytotherapy 2008 10 4 320 330 2-s2.0-47249142875 10.1080/14653240802217011 (Pubitemid 351983156)
11. Reyes M., Lund T., Lenvik T., Aguiar D., Koodie L., Verfaillie C. M., Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 2001 98 2615 2625
12. Vogel W., Grünebach F., Messam C. A., Kanz L., Brugger W., Bühring H., Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cells. Haematologica 2003 88 2 126 133 2-s2.0-0038622954 (Pubitemid 37101490)
13. Sotiropoulou P. A., Perez S. A., Salagianni M., Baxevanis C. N., Papamichail M., Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 2006 24 2 462 471 2-s2.0-33745266607 10.1634/stemcells.2004-0331 (Pubitemid 44464816)
14. Lian Q., Lye E., Suan Yeo K., Khia Way Tan E., Salto-Tellez M., Tong M. L., Palanisamy N., Oakley R. M. W. E., Eng H. L., Lim B., Lim S., Derivation of clinically compliant MSCs from CD105+, CD24-differentiated human ESCs. Stem Cells 2007 25 2 425 436 2-s2.0-33846937043 10.1634/stemcells.2006-0420 (Pubitemid 46232798)
15. Yoon D. S., Kim Y. H., Jung H. S., Paik S., Lee J. W., Importance of Sox2 in maintenance of cell proliferation and multipotency of mesenchymal stem cells in low-density culture. Cell Proliferation 2011 44 5 428 440 2-s2.0-80053168047 10.1111/j.1365-2184.2011.00770.x
16. Cholewa D., Stiehl T., Schellenberg A., Bokermann G., Joussen S., Koch C., Walenda T., Pallua N., Marciniak-Czochra A., Suschek C. V., Wagner W., Expansion of adipose mesenchymal stromal cells is affected by human platelet lysate and plating density. Cell Transplantation 2011 20 9 1409 1422
17. Eslaminejad M. B., Nadri S., Murine mesenchymal stem cell isolated and expanded in low and high density culture system: surface antigen expression and osteogenic culture mineralization. In Vitro Cellular & Developmental Biology-Animal 2009 45 8 451 459
18. Harris S. G., Padilla J., Koumas L., Ray D., Phipps R. P., Prostaglandins as modulators of immunity. Trends in Immunology 2002 23 3 144 150 2-s2.0-0036499224 10.1016/S1471-4906(01)02154-8 (Pubitemid 34178297)
19. 2 cooperation. Expert Opinion on Biological Therapy 2011 11 9 1203 1214 2-s2.0-80051508106 10.1517/14712598.2011.581225
20. 2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells. Experimental Cell Research 2010 316 19 3109 3123 2-s2.0-77958087116 10.1016/j.yexcr.2010.08.008
21. 2 that directs stimulated macrophages into an anti-inflammatory phenotype. Stem Cells 2012 30 2283 2296
22. González S., Groh V., Spies T., Immunobiology of human NKG2D and its ligands. Current Topics in Microbiology and Immunology 2005 298 121 138 2-s2.0-20844458666 (Pubitemid 41508788)
23. Textor S., Fiegler N., Arnold A., Porgador A., Hofmann T. G., Cerwenka A., Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2. Cancer Research 2011 71 18 5998 6009 2-s2.0-80052793188 10.1158/0008-5472.CAN-10-3211
24. Yoo K. H., Jang I. K., Lee M. W., Kim H. E., Yang M. S., Eom Y., Lee J. E., Kim Y. J., Yang S. K., Jung H. L., Sung K. W., Kim C. W., Koo H. H., Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cellular Immunology 2009 259 2 150 156 2-s2.0-70349121293 10.1016/j.cellimm.2009.06.010
25. Zappia E., Casazza S., Pedemonte E., Benvenuto F., Bonanni I., Gerdoni E., Giunti D., Ceravolo A., Cazzanti F., Frassoni F., Mancardi G., Uccelli A., Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 2005 106 5 1755 1761 2-s2.0-23944519424 10.1182/blood-2005-04-1496 (Pubitemid 41208591)
26. Krampera M., Cosmi L., Angeli R., Pasini A., Liotta F., Andreini A., Santarlasci V., Mazzinghi B., Pizzolo G., Vinante F., Romagnani P., Maggi E., Romagnani S., Annunziato F., Role for interferon-γ in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 2006 24 2 386 398 2-s2.0-33746889097 10.1634/stemcells.2005-0008 (Pubitemid 44464808)
27. Chan J. L., Tang K. C., Patel A. P., Bonilla L. M., Pierobon N., Ponzio N. M., Rameshwar P., Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-γ Blood 2006 107 12 4817 4824 2-s2.0-33745076513 10.1182/blood-2006-01-0057 (Pubitemid 43882633)
28. Krampera M., Glennie S., Dyson J., Scott D., Laylor R., Simpson E., Dazzi F., Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003 101 9 3722 3729 2-s2.0-0038204193 10.1182/blood-2002-07-2104 (Pubitemid 36857965)
29. Augello A., Tasso R., Negrini S. M., Amateis A., Indiveri F., Cancedda R., Pennesi G., Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. European Journal of Immunology 2005 35 5 1482 1490 2-s2.0-18844404360 10.1002/eji.200425405 (Pubitemid 40691430)
30. Tse W. T., Pendleton J. D., Beyer W. M., Egalka M. C., Guinan E. C., Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003 75 3 389 397 2-s2.0-0037442264 10.1097/01.TP.0000045055.63901.A9 (Pubitemid 36222968)
31. Djouad F., Plence P., Bony C., Tropel P., Apparailly F., Sany J., Noël D., Jorgensen C., Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003 102 10 3837 3844 2-s2.0-0242410394 10.1182/blood-2003-04-1193 (Pubitemid 37409409)
32. Aggarwal S., Pittenger M. F., Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005 105 4 1815 1822 2-s2.0-13544249606 10.1182/blood-2004-04-1559 (Pubitemid 40223708)
33. Beyth S., Borovsky Z., Mevorach D., Liebergall M., Gazit Z., Aslan H., Galun E., Rachmilewitz J., Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 2005 105 5 2214 2219 2-s2.0-14944339174 10.1182/blood-2004-07-2921 (Pubitemid 40731815)
34. Sato K., Ozaki K., Oh I., Meguro A., Hatanaka K., Nagai T., Muroi K., Ozawa K., Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 2007 109 1 228 234 2-s2.0-33846006154 10.1182/blood-2006-02-002246 (Pubitemid 46053063)
35. + T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. Journal of Immunology 2004 172 7 4100 4110 2-s2.0-1642396607 (Pubitemid 38375222)
36. 2 Blood 2008 111 3 1327 1333 2-s2.0-38949183675 10.1182/blood-2007-02-074997 (Pubitemid 351213419)
37. Tan P. H., Bharath A. K., Manipulation of indoleamine 2,3 dioxygenase; a novel therapeutic target for treatment of diseases. Expert Opinion on Therapeutic Targets 2009 13 8 987 1012 2-s2.0-69149084827 10.1517/ 14728220903018940